Tan, Kathryn C.B.

Prevalence, Treatment, and Control of Diagnosed Diabetes in the U.S. National Health and Nutrition Examination Survey 1999–2004

Ong, K. L., Cheung, B. M. Y., Wong, L. Y. F., Wat, N. M. S., Tan, K. C. B., & Lam, K. S. L. (2008) · Annals of Epidemiology

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 232

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

McClung, M. R., O'Donoghue, M. L., Papapoulos, S. E., Bone, H., Langdahl, B., Saag, K. G., Reid, I. R., Kiel, D. P., Cavallari, I., Bonaca, M. P., et al. (2019) · The Lancet Diabetes & Endocrinology

Bone health and osteoporosis researchMenopause: Health Impacts and Treatments

Cited by 169

Serum advanced glycation end products (AGEs) are associated with insulin resistance

Tan, K. C. B., Shiu, S. W. M., Wong, Y., & Tam, X. (2011) · Diabetes/Metabolism Research and Reviews

Advanced Glycation End Products researchAdipokines, Inflammation, and Metabolic Diseases

Cited by 111

7α-Methyl-19-Nortestosterone Maintains Sexual Behavior and Mood in Hypogonadal Men*

Anderson, R. A., Martin, C. W., Kung, A. W. C., Everington, D., Pun, T. C., Tan, K. C. B., Bancroft, J., Sundaram, K., Moo-Young, A. J., & Baird, D. T. (1999) · The Journal of Clinical Endocrinology & Metabolism

Hormonal and reproductive studiesSexual function and dysfunction studies

Cited by 97

Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease

Lee, C.-H., Lui, D. T.-W., Li, R. H.-W., Yuen, M. M.-A., Fong, C. H.-Y., Leung, A. P.-W., Chu, J. C.-M., Mak, L. L.-Y., Lam, T.-H., Woo, J., et al. (2023) · Frontiers in Endocrinology

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 5